- Fee assured
- Verified this account
- Reproductive medicine
Mr Hamoda is a Consultant Gynaecologist and Subspecialist in Reproductive Medicine and Surgery at King’s College Hospital, London. He qualified in 1994 and was admitted as a member of the Royal College of Obstetricians and Gynaecologists in 2000. He was awarded the degree of Doctor of Medicine (MD) from the University of Aberdeen in 2007. He is accredited as a subspecialist in Reproductive Medicine and Surgery after completion of the subspecialty training programme at Guy’s and St Thomas’ Hospital.
His areas of clinical expertise include infertility and assisted reproduction, menopause and premature ovarian failure, gynaecological ultrasound scanning, gynaecological endocrinology including PCOS, management of fibroids and endometriosis, minimal access surgery, miscarriage and menstrual disorders.
He has published widely in his specialised field, including both book chapters and papers. He is also a co-author of the British Menopause Society guidelines 2013 on the management of the menopause, and is a member of the Medical Advisory Council for the British Menopause Society. In addition, he is actively involved in ongoing research projects both locally and nationally, and teaches at both undergraduate and postgraduate level.
His areas of interests include:
- Open and minimal access surgery (laparoscopic and hysteroscopic)
- Infertility and assisted reproduction
- Menopause and premature ovarian failure
- -Gynaecological ultrasound scanning, contrast sonograpghy for tubal patency and 3D scanning
- Fibroid surgery and management of endometriosis
- General gynaecology and menstrual disorders
- Gynaecological endocrinology including PCOS
Mr Hamoda is an approved healthcare provider for BUPA / AVIVA / AXA PPP / WPA / Cigna Allianz / Healix, Simplyhealth and PruHealth.
Areas of interest
Infertility and assisted conception; Menopause, premature ovarian insufficiency; Minimal access
and open gynaecological surgery/ operative laparoscopy and hysteroscopy, resection of fibroids / polyps; Medical and surgical management of fibroids and endometriosis; Reproductive endocrinology and polycystic ovarian syndrome (PCOS); General gynaecology; gynaecological ultrasound scanning; premenstrual syndrome (PMS),
Anaesthetists worked with (Bupa members, please ask your consultant whether your anaesthetist is fee-assured)
Current NHS consultant posts held
Consultant Gynaecologist, Subspecialist in Reproductive Medicine and Surgery
King's College Hospital
Infertility, menopause, premature menopause, fibroids.
1. The British Menopause Society and Women's Health Concern recommendations on the management of women with premature ovarian insufficiency.
H Hamoda on behalf of the British Menopause Society and Women’s Health Concern.
Post Reprod Health. 2017 Mar;23(1):22-35. doi: 10.1177/2053369117699358. PubMed PMID: 28381102.
2. The British Menopause Society & Women’s Health Concern 2016 recommendations on hormone replacement therapy in menopausal women.
H Hamoda, N Panay, R Arya, and M Savvas on behalf of The British Menopause Society and Women’s Health Concern. Post Reproductive Health
2016, Vol. 22(4) 165–183.
3. The Management of Ovarian Hyperstimulation Syndrome Green-top Guideline No. 5 for the Royal College of Obstetricians and Gynaecologists. February 2016.
RS Mathur, AJ Drakeley, NJ Raine-Fenning, Nottingham, IO Evbuomwan, and H Hamoda.
4. Long-term benefits and risks of HRT (Section 11): Venous thromboembolism.
Hamoda H. Post Reproductive Health. 22 (2); (77-79), 2016.
5. Intermediate and long-term outcomes following uterine artery fibroid embolization.
Hamoda H, Pepas L, Tasker F, Reidy J, Khalaf Y.
Eur J Obstet Gynecol Reprod Biol. 2015 Aug;191:33-8. doi: 10.1016/j.ejogrb.2015.05.016.
6: Seshadri S, Sunkara SK, Khalaf Y, El-Toukhy T, Hamoda H. Effect of heparin on
the outcome of IVF treatment: a systematic review and meta-analysis. Reprod
Biomed Online. 2012 Dec;25(6):572-84.
7: Hamoda H, Pepas L, Freed C, Grace J, Khalaf Y, Braude P, El-Toukhy T. Outcomes
of ovarian stimulation in a two-day oocyte collection week with PGD cycles
compared to a five-day oocyte collection week with conventional IVF/ICSI cycles.
Hum Fertil (Camb). 2011 Dec;14(4):254-60.
8. New guidelines for hormone-replacement therapy: An update on risks and benefits for clinical practice.
Hamoda H., Savvas M., Panay N.
Clinical Practice. 10 (6) (pp 675-678), 2013. Date of Publication: November 2013.
- MBChB Baghdad University 1994
- FRCOG Member ship of Royal College of Obstetricians and Gynaecologists 1994
- MD University of Aberdeen 2007
- Subspecialty training in reproductive medicine and surgery Guy's and St Thomas' Hospital 2011
Reference number 4679079
Affiliations / memberships
Member of the Medical Advisory Council for the British Menopause Society
British Fertility Society
European Society of Human Reproduction
Faculty of Sexual & Reproductive Healthcare
British Society for Gynaecological Endoscopy
- 27 Tooley StreetLONDONSE1 2PR
- 17:00 - 20:00
- 07708 474363
- BMI The Sloane Hospital, BR3 5HS
- 09:00 - 10:00
- 07708 474363
- King's College Hospital, Denmark Hill, LONDON
- 17:00 - 19:00
- 07708 474363
- Lister Hospital, SW1W 8RH
- 12:00 - 14:00
- 07708 474363
Post treatment communication
Following treatment of a Bupa member, I will communicate with GPs in line with Department of Health, GMC and appropriate professional bodies guidelines.
In the event of an urgent query following treatment, Bupa members should use the following contact details
07554 380 418